The FULL speaking faculty for the 5th Annual Drug Repositioning Conference has not yet been announced. Please check back in the coming weeks and months for additional information. Speakers to date include:
Dr. Bruce E. Bloom, President and Chief Science Officer, Cures Within Reach
Leslie Cousens, Ph.D., Associate Director, Translational Medicine, Emerging Innovations, AstraZeneca
Matthew DeSilva, CEO, Notable Labs
Nandu Gattu, Ph.D., VP Drug Repurposing, Excelra - Knowledge Solutions
Katsuhisa Horimoto, Ph.D., Deputy Director, Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology
Kim Kaiser-Rachidi, Special Consultant-Industry Relations, Alliance for Lupus Research
Burcu Kucukkeles, Research Associate & Doctoral Candidate, Department of Management, Technology and Economics, Chair of Strategic Management and Innovation, ETH Zurich
Daphna Laifenfeld, Ph.D., Director, Personalized and Predictive Medicine and Big Data Analytics, Teva Pharmaceuticals
Vimal Mehta, Ph.D., Chairman and Chief Executive Officer, BioXcel
Hermann Mucke, Ph.D., Principal, HM Pharma Consultancy
Stephen Naylor, Ph.D., Chairman & CEO, MaiHealth Inc.
Aytekin Oto, MD, Professor of Radiology, Section Chief, Abdominal Imaging, Chief of Body MRI, The University of Chicago
Aris Persidis, Ph.D., President, Biovista
Kenneth Phelps, President and CEO, Camargo Pharmaceutical Services
Lakshminarayan Ranganath, Ph.D., Director, National AKU Centre, Coordinator, DevelopAKUre Consortium, Honorary Professor in Musculoskeletal Biology, University of Liverpool, Consultant, Royal Liverpool University Hospital
Al Roy, Executive Director, Lupus Clinical Investigators Network, Alliance for Lupus Research
Adriann Sax, MBA, Entrepreneur in Residence, Fortress Biotech
Daniel Sem, Ph.D., MBA, Dean and Professor of Business, Professor of Pharmaceutical Sciences, Concordia University Wisconsin
Larry Sklar, Ph.D., The Maralyn S. Budke and Robert E. Anderson Distinguished Endowed Chair in Cancer Drug Discovery, Director, UNM Center for Molecular Discovery, The University of New Mexico School of Medicine
Paul Spagnuolo, Ph.D., Assistant Professor, University of Waterloo
Marty St. Clair, Ph.D., Clinical Virology, ViiV Healthcare
Vikram Sudarsan, Head, Cipla Technologies, Cipla New Ventures
Rose Thiessen, Ph.D., Partner, Knobbe, Martens, Olson & Bear, LLP
Jason Tsai, MD, MS, VP Translational Medicine, Numedii
Jerome Zeldis, MD, Ph.D., Chief Executive Officer, Celgene Global Health, Chief Medical Officer, Celgene Corporation
Alice Zhang, Chief Executive Officer, Verge Genomics
Wei Zheng, Ph.D., Leader, Biology, Therapeutics for Rare and Neglected Diseases, Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health